A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2001
10/25/2001	CA2406192A1 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001	CA2406126A1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family
10/25/2001	CA2406121A1 Novel nucleic acids and polypeptides
10/25/2001	CA2406039A1 Materials and methods relating to lipid metabolism
10/25/2001	CA2406019A1 Repair of ruptured membrane by injection of naturally occurring protein in amniotic fluid sac
10/25/2001	CA2405946A1 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405753A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405600A1 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405555A1 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405548A1 Steatosis-modulating factors and uses thereof
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2405247A1 Tuberculosis antigens and methods of use thereof
10/25/2001	CA2405078A1 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/25/2001	CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001	CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001	CA2404097A1 Method and compositions for preventing hormone induced adverse effects
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/25/2001	CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001	CA2399940A1 Enhancement of antibody-mediated immune responses
10/25/2001	CA2376655A1 Modulating cell survival by modulating huntingtin function
10/25/2001	CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain
10/24/2001	EP1148129A1 Betacellulin modification
10/24/2001	EP1148128A1 Gene locus involved in regulating hair pigmentation, vestibular function and fertility
10/24/2001	EP1148127A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor). Its uses
10/24/2001	EP1148126A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor)
10/24/2001	EP1148065A1 Fusion proteins comprising two soluble gp130 molecules
10/24/2001	EP1148064A1 Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori
10/24/2001	EP1148050A1 Retroviral protease inhibitors
10/24/2001	EP1147777A1 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
10/24/2001	EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms
10/24/2001	EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
10/24/2001	EP1147770A1 Virginiamycin mixture
10/24/2001	EP1147420A1 Urinary trypsin inhibitor to diagnose aids
10/24/2001	EP1147413A2 Growth differentiation factor inhibitors and uses therefor
10/24/2001	EP1147227A1 Lipophilic quenching of viral inactivating agents
10/24/2001	EP1147223A1 Identifying, monitoring, and treating women for breast precancer or cancer
10/24/2001	EP1147213A2 Novel rgs-containing molecules and uses thereof
10/24/2001	EP1147212A1 T helper cell epitopes
10/24/2001	EP1147208A2 Compositions and methods for intraductal gene therapy
10/24/2001	EP1147205A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
10/24/2001	EP1147202A2 Plasminogen kringle 4 region fragments and methods of use
10/24/2001	EP1147201A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
10/24/2001	EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
10/24/2001	EP1147191A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
10/24/2001	EP1147190A1 Her-2/neu fusion proteins
10/24/2001	EP1147189A2 Ribozyme therapy for the treatment and/or prevention of restenosis
10/24/2001	EP1147188A1 Internal ribosome entry site (ires), vector containing same and the uses thereof
10/24/2001	EP1147182A2 Human beta-1,3-galactosyltransferase homolog, znssp6
10/24/2001	EP1147178A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
10/24/2001	EP1147175A2 Fibres for culturing eukaryotic cells
10/24/2001	EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001	EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
10/24/2001	EP1147132A2 Antiviral peptides
10/24/2001	EP1147131A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
10/24/2001	EP1147130A1 Alpha-conotoxin peptides
10/24/2001	EP1147129A1 Saccharides linked to compounds that bind cell-surface peptides or proteins
10/24/2001	EP1147125A1 Brain-derived alkali-soluble immunoregulatory composition
10/24/2001	EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/24/2001	EP1147011A1 Interferon-alpha mediated upregulation of aquaporin expression
10/24/2001	EP1146913A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
10/24/2001	EP1146908A1 Formulations comprising antisense nucleotides to connexins
10/24/2001	EP1146903A1 Glypicans for the detection and treatment of human carcinoma
10/24/2001	EP1146902A1 Treatment of autommune diseases by an agonistic cd40-binding protein
10/24/2001	EP1146901A1 Potentiation of anti-cd38-immunotoxin cytotoxicity
10/24/2001	EP1146899A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
10/24/2001	EP1146897A1 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
10/24/2001	EP1146896A2 Monodisperse hexameric acylated insulin analog formulations
10/24/2001	EP1146895A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
10/24/2001	EP1146894A1 Uses of thank, a tnf homologue that activates apoptosis
10/24/2001	EP1146893A1 Neurite derived growth factors for use in the treatment of muscular dystrophy
10/24/2001	EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001	EP1146891A1 Inhibiting development of microvessels within vascular walls
10/24/2001	EP1146890A2 Buccal delivery system for proteinaceous medicaments
10/24/2001	EP1146889A2 Identification of specific differentially expressed mycobacterial antigens
10/24/2001	EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting
10/24/2001	EP1146887A1 Glycopeptide antibiotics containing a desmethylvancosamine residue, combinatorial libraries of same and methods of producing same
10/24/2001	EP1146881A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
10/24/2001	EP1146869A2 Inhibition of stat3 signal transduction for human cancer therapy
10/24/2001	EP1146861A1 Hydrogel particle formulations
10/24/2001	EP1146858A1 Non-invasive vaccination through the skin
10/24/2001	EP1146857A2 Materials and methods for making improved micelle compositions
10/24/2001	EP1146794A1 A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
10/24/2001	EP1146787A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
10/24/2001	EP0919567B1 Novel peptides and nootropic agent
10/24/2001	EP0820433B1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/24/2001	EP0809698B1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
10/24/2001	EP0801686B1 Process for preparing cyclosporin a
10/24/2001	EP0791077A4 Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter
10/24/2001	EP0731709B1 Neutrophil inhibitors from nematodes
10/24/2001	EP0721957B1 Compound ge3
10/24/2001	EP0618802B1 Synthetic compounds and compositions with enhanced cell binding
10/24/2001	EP0593754B1 Peptides of human papilloma virus for use in human t cell response inducing compositions

1 ... 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 ... 3163